Imatinib Enhances Functional Outcome after Spinal Cord Injury

We investigated whether imatinib (Gleevec®, Novartis), a tyrosine kinase inhibitor, could improve functional outcome in experimental spinal cord injury. Rats subjected to contusion spinal cord injury were treated orally with imatinib for 5 days beginning 30 minutes after injury. We found that imatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrams, Mathew B., Nilsson, Ingrid, Lewandowski, Sebastian A., Kjell, Jacob, Codeluppi, Simone, Olson, Lars, Eriksson, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378614/
https://www.ncbi.nlm.nih.gov/pubmed/22723886
http://dx.doi.org/10.1371/journal.pone.0038760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378614/
https://www.ncbi.nlm.nih.gov/pubmed/22723886
http://dx.doi.org/10.1371/journal.pone.0038760

Ejemplares similares